宫颈癌前哨淋巴结微转移的研究进展

doi:10.11904/j.issn.1002-3070.2018.06.018

实用肿瘤学杂志 ›› 2018, Vol. 32 ›› Issue (6): 571-574.doi: 10.11904/j.issn.1002-3070.2018.06.018

宫颈癌前哨淋巴结微转移的研究进展

秦文艳综述, 卢艳审校

广西医科大学附属肿瘤医院妇瘤2病区(南宁 530021)

收稿日期:2018-07-18 出版日期:2018-12-28 发布日期:2018-12-27
通讯作者: 卢艳, E-mail:kitty9500@163.com
作者简介:秦文艳, 女, (1991-), 硕士研究生, 从事妇科肿瘤的研究。
基金资助:
广西医疗卫生适宜技术开发与推广应用项目(编号:S2017100);广西重点研发计划(编号:桂科AB17292092)

Advances in micrometastasis of sentinel lymph node in cervical cancer

QIN Wenyan, LU Yan

Department of Gynecologic Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, China

Received:2018-07-18 Online:2018-12-28 Published:2018-12-27

摘要/Abstract

摘要： 宫颈癌主要的转移途径为淋巴结转移, 前哨淋巴结是肿瘤发生淋巴结转移的第一站。淋巴结转移是由淋巴结微转移发展而来, 然而淋巴结微转移通常被传统的病理组织学检测忽略, 未能发现的微转移有可能导致复发。本文将介绍近年来宫颈癌前哨淋巴结微转移的研究进展。

关键词: 宫颈癌, 前哨淋巴结, 微转移

Abstract: The main metastatic pathway for cervical cancer is lymph node metastasis.Sentinel lymph nodes are the first site of lymph node metastasis.Lymph node metastasis is a result of lymph node micrometastasis.However, lymph node micrometastasis is usually neglected by traditional histopathology, and undetected lymph node micrometastases may lead to recurrence.This article will introduce the progress of research on sentinel lymph node micrometastasis in cervical cancer in recent years.

Key words: Cervical cancer, Sentinel lymph node, Micrometastasis

中图分类号:

R737.33

秦文艳综述, 卢艳审校. 宫颈癌前哨淋巴结微转移的研究进展[J]. 实用肿瘤学杂志, 2018, 32(6): 571-574.

QIN Wenyan, LU Yan. Advances in micrometastasis of sentinel lymph node in cervical cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 571-574.

参考文献

1 Durst M, Hoyer H, Altgassen C, et al.Prognostic value of HPV-mRNA in sentinel lymph nodes of cervical cancer patients with pN0-status[J].Oncotarget, 2015, 6(26):23015-23025.
2 Sartori E, Tisi G, Chiudinelli F, et al.Early stage cervical cancer:Adjuvant treatment in negative lymph node cases[J].Gynecologic Oncology, 2007, 107(1):170-174.
3 马晓洁, 李莎莎, 谭榜宪.宫颈癌淋巴结微转移的研究进展[J].现代妇产科进展, 2015, 24(4):303-305.
4 于正洪, 姜恩泽, 王新星, 等.肿瘤休眠期细胞的研究进展[J].临床肿瘤学杂志, 2014, 19(2):172-175.
5 Diab Y.Sentinel lymph nodes mapping in cervical cancer a comprehensive review[J].Int J Gynecol Cancer, 2017, 27(1):154-158.
6 Zigras T, Lennox G, Willows K, et al.Early cervical cancer:current dilemmas of staging and surgery[J].Curr Oncol Rep, 2017, 19(8):51.
7 Tortora M, Annunziata C, Liguori G, et al.Detection of human papillomavirus DNA in peri-tumor tissues and pelvic lymph nodes as potential molecular marker of micrometastasis in cervical cancer[J].Infect Agent Cancer, 2016, 11:22.
8 蒋燕明, 杨岚, 弋文娟.早期宫颈癌前哨淋巴结中高危型HPV16/18 DNA表达的检测及临床意义[J].癌症进展, 2016, 14(6):597-600.
9 de Freitas RR, Baiocchi G, Hatschbach SBB, et al.Can a sentinel node mapping algorithm detect all positive lymph nodes in cervical cancer?[J].Ann Surg Oncol, 2015, 22(5):1564-1569.
10 Okamoto S, Niikura H, Nakabayashi K, et al.Detection of sentinel lymph node metastases in cervical cancer:Assessment of KRT19 mRNA in the one-step nucleic acid amplification(OSNA)method[J].Gynecologic Oncology, 2013, 130(3):530-536.
11 李琳, 邢辉, 覃小敏, 等.CK19表达与子宫颈癌前哨淋巴结转移的关系[J].实用癌症杂志, 2016, 31(3):387-389.
12 马永静.SCCAg、CK1 9 mRNA与早期宫颈癌前哨淋巴结微转移的相关性研究[J].宁夏医学杂志, 2013, 35(11):1038-1040.
13 Zhou Z, Li W, Zhang F, et al.The value of squamous cell carcinoma antigen(SCCa)to determine the lymph nodal metastasis in cervical cancer:A meta-analysis and literature review[J].PLoS One, 2017, 12(12):e186165.
14 Ren J, Zhou ZL, Xu S, et al.Prognostic significance of cytokeratin 19 and squamous cell cancer antigen in histologically negative sentinel lymph nodes of cervical squamous cell carcinoma[J].Int J Gynecol Cancer, 2016, 26(9):1679-1685.
15 Cibula D, Abu-Rustum NR, Dusek L, et al.Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer[J].Gynecologic Oncology, 2012, 124(3):496-501.
16 Stany MP, Stone PJB, Felix JC, et al.Lymph node micrometastases in early-stage cervical cancer are not predictive of survival[J].Int J Gynecol Pathol, 2015, 34(4):379-384.
17 Colturato LF, Signorini Filho RC, Fernandes RCM, et al.Lymph node micrometastases in initial stage cervical cancer and tumoral recurrence[J].Int J Gynecol Obstet, 2016, 133(1):69-75.
18 Salvo G, Ramirez PT, Levenback CF, et al.Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer[J].Gynecol Oncol, 2017, 145(1):96-101.
19 Tax C, Rovers MM, de Graaf C, et al.The sentinel node procedure in early stage cervical cancer, taking the next step;a diagnostic review[J].Gynecol Oncol, 2015, 139(3):559-567.
20 NCCN clinical practice guidelines in Oncology:cervical cancer(2018.V1)[EB/OL].https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf.
21 Cibula D, Abu-Rustum NR, Dusek L, et al.Bilateral ultrastaging of sentinel lymph node in cervical cancer:Lowering the false-negative rate and improving the detection of micrometastasis[J].Gynecol Oncol, 2012, 127(3):462-466.
22 Beavis AL, Salazar-Marioni S, Sinno AK, et al.Sentinel lymph node detection rates using indocyanine green in women with early-stage cervical cancer[J].Gynecol Oncol, 2016, 143(2):302-306.
23 Bezu C, Coutant C, Ballester M, et al.Ultrastaging of lymph node in uterine cancers[J].J Exp Clin Cancer Res, 2010, 29(1):5.
24 Dostálek L, Zikan M, Fischerova D, et al.SLN biopsy in cervical cancer patients with tumors larger than 2 cm and 4 cm[J].Gynecol Oncol, 2018, 148(3):456-460.
25 Cibula D, Zikan M, Slama J, et al.Risk of micrometastases in non-sentinel pelvic lymph nodes in cervical cancer[J].Gynecol Oncol, 2016, 143(1):83-86.
26 Kim CH, Soslow RA, Park KJ, et al.Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging[J].Int J Gynecol Pathol, 2013, 23(5):964-970.
27 Deng X, Zhang Y, Li D, et al.Abdominal radical trachelectomy guided by sentinel lymph node biopsy for stage IB1 cervical cancer with tumors ＞2 cm[J].Oncotarget, 2017, 8(2):3422-3429.
28 Slama J, Dundr P, Dusek L, et al.High false negative rate of frozen section examination of sentinel lymph nodes in patients with cervical cancer[J].Gynecologic Oncology, 2013, 129(2):384-388.
29 Sonoda K, Yahata H, Okugawa K, et al.Value of Intraoperative Cytological and Pathological Sentinel Lymph Node Diagnosis in Fertility-Sparing Trachelectomy for Early-Stage Cervical Cancer[J].Oncology, 2018, 94(2):92-98.

[1]	梁虹, 李奇, 王耀先, 靳红, 王铜, 王亚楠, 段雅妮, 宋敏. 宫颈癌化疗心血管毒性预防的间断时间序列试验[J]. 实用肿瘤学杂志, 2019, 33(2): 134-138.
[2]	成海燕, 马晶, 冯紫微, 黄可金, 王玉霞, 张云艳. 抑癌基因PRDM5在HPV16病毒致宫颈鳞癌发生过程中的作用研究[J]. 实用肿瘤学杂志, 2018, 32(6): 483-487.
[3]	付艳丽, 余杨, 卫玮, 邹晶晶, 孙翔. 高危型人乳头状瘤病毒载量和Th1/Th2不均衡表达预测宫颈癌变进程的研究[J]. 实用肿瘤学杂志, 2018, 32(6): 533-537.
[4]	王一然, 黄维, 尹蕾, 刘琳, 周晓平, 牛星鉴, 杨悦, 安巍巍, 姬宏飞. 中性粒细胞与淋巴细胞比值对宫颈癌患者同步放化疗疗效及预后判断的临床意义[J]. 实用肿瘤学杂志, 2018, 32(5): 404-409.
[5]	孟志英, 于松涛, 张晶晶, 金惠敏. 宫颈癌下颌骨转移1例报告并文献复习[J]. 实用肿瘤学杂志, 2018, 32(2): 122-124.
[6]	毕琦玲, 周立红, 韩毅敏. HOX基因与妇科肿瘤的研究进展[J]. 实用肿瘤学杂志, 2018, 32(2): 140-143.
[7]	王庆辉, 孙悦, 姜万维. 探讨氟比洛芬酯应用于宫颈癌手术术后镇痛的临床效果[J]. 实用肿瘤学杂志, 2018, 32(1): 33-37.
[8]	雷蕾, 叶庆华, 王国增, 黄贤莉, 吴乾渝. Aurora-A在宫颈癌及癌前病变中的表达以及与HPV感染的相关性研究[J]. 实用肿瘤学杂志, 2017, 31(6): 494-499.
[9]	于德洋, 杨姗姗, 云惟康, 冯丽娜, 白彦灵. 宫颈癌术后容积弧形调强与固定野动态调强放疗技术的剂量学比较[J]. 实用肿瘤学杂志, 2017, 31(2): 152-155.
[10]	曲亚兰, 谢宝芳, 李丹阳. 流式细胞术联合阴道镜活检在宫颈癌和癌前病变筛查中的意义[J]. 实用肿瘤学杂志, 2017, 31(1): 31-34.
[11]	杨毅，丁妍，于爱清，严世荣. 自噬对宫颈癌细胞增殖和迁移能力的影响[J]. 实用肿瘤学杂志, 2016, 30(6): 481-486.
[12]	吴煜良，何松美，张纯，吴伟艺，崔顺景，赵艳海. 迭代次数在宫颈癌术后调强放疗计划中对子野权重优化的影响[J]. 实用肿瘤学杂志, 2016, 30(6): 507-510.
[13]	盛磊, 武贵臻, 胡尔西旦·尼牙孜, 阿布力孜·阿布杜拉. 维吾尔族宫颈癌患者Th1/Th2型细胞因子表达水平及临床意义[J]. 实用肿瘤学杂志, 2016, 30(5): 391-395.
[14]	王振骏, 周洪贵, 张苗, 刘均. 意外发现宫颈癌1例及文献复习[J]. 实用肿瘤学杂志, 2016, 30(5): 441-443.
[15]	侯立春,林黎娟. NQO1高表达提示宫颈癌预后不良[J]. 实用肿瘤学杂志, 2016, 30(4): 351-355.

宫颈癌前哨淋巴结微转移的研究进展

Advances in micrometastasis of sentinel lymph node in cervical cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价